Facebook Linkedin RSS Twitter Youtube
Home 2022

Natural killer cells

Current and Future CEOs See Opportunities in Editas’ Challenges
Drug Discovery

Current and Future CEOs See Opportunities in Editas’ Challenges

Nektar Eliminates 70% of Workforce, 500+ Jobs, in Restructuring
Drug Discovery

Nektar Eliminates 70% of Workforce, 500+ Jobs, in Restructuring

Severe COVID-19 Hallmark Found in Untimely Production of TGFβ
Coronavirus

Severe COVID-19 Hallmark Found in Untimely Production of TGFβ

MIS-C in Children May Be Driven by T-Cell Exhaustion
Coronavirus

MIS-C in Children May Be Driven by T-Cell Exhaustion

Vintage “Chardonnay:” Caribou Biosciences Files for $100M IPO
Cancer

Vintage “Chardonnay:” Caribou Biosciences Files for $100M IPO

CAR-NK Immunotherapy Targets Cancer Cells, Spares Healthy Cells Carrying Same Markers
Cancer

CAR-NK Immunotherapy Targets Cancer Cells, Spares Healthy Cells Carrying Same Markers

Cellares’ Automation Route for Cancer Cell Therapy
Cancer

Cellares’ Automation Route for Cancer Cell Therapy

Overcoming Immune Suppression in Glioblastoma with Engineered NK Cells
Cancer

Overcoming Immune Suppression in Glioblastoma with Engineered NK Cells

‘Manufacturing-First Approach’ Pays Off for Cell Therapy Developer Artiva
Cancer

‘Manufacturing-First Approach’ Pays Off for Cell Therapy Developer Artiva

Doubling Up on Single Cell
Artificial Intelligence

Doubling Up on Single Cell

1234...8Page 3 of 8
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.